News: Featured
Friday, March 18th, 2011
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The findings, reported in two papers in the Proceedings of the National Academy of Sciences (PNAS), suggest that upregulation of the HER3 receptor limits the effectiveness of two classes [...]
Posted in Breast Cancer, Cancer News, Clinical Trials, Home Page Clinical Trials, Home Page Latest News, Women's Cancers | Comments Off
Tuesday, March 8th, 2011
Vanderbilt-Ingram Cancer Center has appointed Michael Neuss, M.D., as chief medical officer for its clinical enterprise. A Duke-trained oncologist in practice since 1986, Neuss was, until December, the vice president of the largest oncology practice in the Cincinnati area. He assumes the newly created position July 1. Neuss will report to C. Wright Pinson, MBA, [...]
Posted in Cancer News, Home Page Latest News | Comments Off
Wednesday, January 12th, 2011
Nashville, Tenn. – Seven Vanderbilt University faculty members, including 6 who are members of the Vanderbilt-Ingram Cancer Center, have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon them by their AAAS peers. They are among 503 AAAS members from around the country who achieved this honor [...]
Posted in Cancer News, Cancer Research, Drug Discovery, Home Page Latest News, Radiation Oncology | Comments Off
Thursday, June 17th, 2010
Richard Peek, M.D., laughs at the memory of his introduction to Helicobacter pylori – a twisted sausage-shaped bacterium that takes up residence in the human stomach. He was a medical student at the time – around 1987 – and was following a patient with a bleeding ulcer. The patient had an endoscopy procedure to view [...]
Posted in Cancer Research, Gastrointestinal Cancer, Momentum | 1 Comment »
Thursday, June 17th, 2010
On iTunes U, a lecturer predicts that we will one day be routinely giving drugs to computers. When you get sick, someone will load your medical history and your genome sequence (and perhaps other selected data about your biochemical composition) into a simulator. As various drugs are entered, you’ll learn of their predicted effects in [...]
Posted in Cancer Research, Momentum, Personalized Oncology, Quality of Care | Comments Off
Thursday, June 17th, 2010
In an economic crisis that has led to some of the highest unemployment rates since the Great Depression, Sergey Ivanov, Ph.D., is very relieved to have found a position at Vanderbilt-Ingram Cancer Center. Ivanov’s wife had accepted a new position at Vanderbilt, so the couple moved from New York to Nashville in 2009. But Ivanov [...]
Posted in Breast Cancer, Cancer Research, Drug Discovery, Head and Neck Cancer, Lung Cancer, Momentum, Personalized Oncology, Radiation Oncology | Comments Off
Thursday, June 17th, 2010
Ilana Horn first discovered Facebook in 2006 after her brother died of a rare form of prostate cancer at only 36. In her search for photos, his friends directed her to a memorial page on the social networking site that connects family and friends. “At that time of great grief, it was very important to [...]
Posted in Momentum, Survivorship | 1 Comment »
Join Us